The K * algorithm provably approximates partition functions for a set of states (e.g., protein, ligand, and protein-ligand complex) to a user-specified accuracy ε. Often, reaching an ε-approximation for a particular set of partition functions takes a prohibitive amount of time and space. To alleviate some of this cost, we introduce two algorithms into the osprey suite for protein design: fries, a Fast Removal of Inadequately Energied Sequences, and EWAK * , an Energy Window Approximation to K * . In combination, these algorithms provably retain calculational accuracy while limiting the input sequence space and the conformations included in each partition function calculation to only the most energetically favorable. This combined approach leads to significant speed-ups compared to the previous state-of-the-art multi-sequence algorithm, BBK * . As a proof of concept, we used these new algorithms to redesign the protein-protein interface (PPI) of the c-Raf-RBD:KRas complex. The Ras-binding domain of the protein kinase c-Raf (c-Raf-RBD) is the tightest known binder of KRas, a September 25, 2019 1/34 historically "undruggable" protein implicated in difficult-to-treat cancers including pancreatic ductal adenocarcinoma (PDAC). fries/EWAK * accurately retrospectively predicted the effect of 38 out of 41 different sets of mutations in the PPI of the c-Raf-RBD:KRas complex. Notably, these mutations include mutations whose effect had previously been incorrectly predicted using other computational methods. Next, we used fries/EWAK * for prospective design and discovered a novel point mutation that improves binding of c-Raf-RBD to KRas in its active, GTP-bound state (KRas GTP ).
sequences and conformations. EWAK * , an Energy Window Approximation to K * , seeks 48 to alleviate some of this difficulty by restricting the conformations included in each [47] ) and the osprey workflow for fries/EWAK * . In the top panel, the full, 4 domain structure of lectin is shown on the left-hand side. (A) Zooming in on the region where domains A (green) and D (yellow) interact, showing the two mutable residues (Q80 and I82) along with the surrounding flexible shell of residues as lines. There were 11 flexible residues included in this design with Q80 and I82 allowed to mutate to all other amino acids except for proline. This design consisted of 8.102 × 10 11 conformations and 441 sequences. fries limited this space to 5.704 × 10 11 conformations and 206 sequences. fries/EWAK * in combination reduced the amount of time taken by about 75% compared to BBK * . fries alone was responsible for roughly 50% of this speed-up. (B) 10 low-energy conformations included in the thermodynamic ensemble of the design sequence with mutations Q80I and I82F. For this particular sequence, BBK * minimized 10,664 conformations while EWAK * minimized only 4,104 conformations. The bottom panel shows the general workflow for fries/EWAK * . The workflow begins with the input model (as described in the Section entitled "Introduction"), which defines the design space for the first algorithm, fries. fries proceeds to prune the sequence space as described in the Section entitled "Fast Removal of Inadequately Energied Sequences (fries)" and as illustrated in the Venn diagram with the unpruned space shown as a yellow disk. Next, the remaining fries sequence space defines the conformation space (which contains multiple sequences as well as conformations) searched with EWAK * . EWAK * limits the conformations included in each partition function as described in the Section entitled "Energy Window Approximation to K* (EWAK * )." EWAK * generally searches over only a subset of the conformations (green area) that previous K * -based algorithms like BBK * [32] search (orange area). EWAK * then returns the top sequences based on decreasing K * score.
near-optimal for their corresponding folds [46] . Therefore, limiting the sequence space 61 to sequences energetically similar to or better than the wild-type sequence is reasonable. 62 A simplified workflow for fries/EWAK * is presented in Fig 1. Compared to the 63 previous state-of-the-art algorithm BBK * , fries and EWAK * improve runtimes by up 64 to 2 orders of magnitude, fries decreases the size of the sequence space by up to more 65 than 2 orders of magnitude, and EWAK * decreases the number of conformations 66 included in partition function calculations by up to almost 2 orders of magnitude. design algorithms approximate these partition functions for each state using either 104 stochastic [50] [51] [52] [53] or provable [2, 12, 29-31, 33, 53] methods. 105 osprey's K * algorithm provably approximates these partition functions to within a 106 user-specified ε of the full partition function as defined in Eq (1) . The binding affinity 107 for sequence s is defined as:
The K * algorithm provably approximates this binding affinity. This is enabled by 109 the use of A * [4, 12, 26, 54] , which allows for the gap-free enumeration of conformations 110 in order of increasing lower bounds on energy [26] . However, enumerating a sufficient 111 number of these conformations to obtain a guaranteed ε-approximation can be very 112 time consuming because the set of all conformations Q(s) grows exponentially with the 113 number of residues n. Also, the K * algorithm was originally [12, 29, 30] scores"), which leads to significant speed-ups (see the Section entitled "fries/EWAK * relatively expensive, therefore, anything that reduces the number of minimized conformations while not sacrificing provable accuracy is desirable. For the importance 134 of this minimization step to biological accuracy, see the discussions of continuous 135 flexibility and its comparison to discrete flexibility in [4, 5, 7, 13, 14, 19] . EWAK * also 136 maintains the advances made by BBK * including running in time sublinear in the 137 number of sequences N and returning sequences in order of decreasing K * score. fries 138 and EWAK * are described in further detail in the Section entitled "Algorithms" below. 139 [2, 37, 38] . Importantly, fries does still allow for sequences that may have 154 lower, worse partition function values by allowing the user to specify how many orders 155 of magnitude lower a candidate sequence's partition function is allowed to be relative to 156 the wild-type sequence's partition function.
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sequences (in order of energy lower bounds) in the multi-sequence tree until the 163 wild-type sequence is found. Then, fries searches the wild-type's corresponding 164 single-sequence conformation tree using A * . The first conformation enumerated 165 according to monotonic lower bound on pairwise minimized energy is then subjected to 166 a full-atom minimization [30] to calculate the minimized energy of one of the wild-type 167 sequence's conformations E W T . fries then continues enumerating sequences in the 168 multi-sequence tree in order of increasing lower bound on minimized energy until the 169 lower-bound on the energy of a sequence v, E v , is greater than E W T + w where E W T is 170 as described above and w is a user-specified energy window value (Fig 2) . Any variant 171
sequence v with a lower bound on minimized energy E v not satisfying the following 172 criterion is pruned:
This criterion guarantees that the remaining, unpruned sequence space includes all 174 sequences within an energy window of the wild-type sequence's energy. fries 175 enumerates sequences in order of increasing lower bound on minimized energy.
176
Therefore, it calculates an upper bound q ⊕ v on the partition function for each sequence v 177 by Boltzmann-weighting the lower bound on its energy E v and multiplying it by the 178 size of the conformation space for that particular sequence |Q(v)|:
The lower bound for the wild-type sequence q W T is calculated by 180 Boltzmann-weighting the minimized energy of the single conformation found during the 181 sequence search for the wild-type sequence E W T :
q W T is a lower bound because, in the worst case, at least this one conformation will 183 contribute to the partition function for the wild-type sequence. fries then uses these 184 bounds to remove all of the sequences whose partition function value is not within some 185 user-specified m orders of magnitude of the lower bound on the wild-type partition function q W T . If the following criterion is not met, the sequence v is pruned from the 187 space:
fries prunes sequences for the protein, the ligand, and the protein-ligand complex 189 independently, limiting the input sequence space to exclude unfavorable sequences for 190 all of the states. The resulting smaller sequence space is subsequently used as input for 191 EWAK * . The set of sequences remaining is guaranteed to include all of the sequences 192 within a user-specified energy window w of the wild-type sequence that also satisfy the 193 partition function criterion given in Eq (4) . Importantly, fries can be used to limit the 194 size of the input sequence space in this fashion for any of the protein design algorithms 195 available within osprey. prune. The solid curve represents the energy landscape of the conformation space that spans across, in this example, 7 different sequences (separated by dotted lines). Each sequence is labeled on the x-axis with an index indicating the order with which it is (or would be) enumerated with fries in order of increasing lower bound on minimized energy (red dotted curve). fries continues to enumerate in this way until it encounters the wild-type sequence (green), at which point fries calculates the minimized energy E W T of the conformation with the lowest lower bound on minimized energy for the wild-type sequence (marked with a green dot). E W T then becomes the baseline from which fries can provably enumerate all remaining sequences within some user-specified energy window w (yellow lines). Finally, fries prunes the sequences with energies provably higher than E W T + w (black) and keeps the sequences that occur within the shaded yellow region (colored in blue and green). More sequences are also pruned according to their partition function values as described in the Section entitled "Fast Removal of Inadequately Energied Sequences (fries)" and as defined by Eq (4).
Energy Window Approximation to K* (EWAK * ). After reducing the size of the 197 input sequence space using fries, as described in the Section entitled "Fast Removal of 198
Inadequately Energied Sequences (fries)," EWAK * proceeds by using a variation on an 199 existing algorithm: BBK * (described in [32] ). The crucial difference between BBK * and 200 EWAK * is that with EWAK * the ensemble of conformations used to approximate each 201 K * score is limited to those within a user-specified energy window of the GMEC for 
226
Using BBK * and fries/EWAK * , we computed the top 5 best binding sequences for 167 227 different designs to compare the running time of BBK * vs. fries/EWAK * . fries was 228 limited to sequences within 4 kcal/mol of the wild-type sequence that are at most 2 229 orders of magnitude worse in partition function values than the wild-type. The EWAK * 230 partition function approximations were limited to conformations within an energy 231 window of 1 kcal/mol of the GMEC for each sequence. BBK * was set to return the top 232 5 sequences with an accuracy of ε = 0.68 (as was described in [32] ). Using these same 233 for 661 partition functions from 161 design examples. The results for these tests are 236 described in Sections entitled "fries/EWAK * is up to 2 orders of magnitude faster than 237 BBK*" and "fries can reduce the size of the input sequence space by more than 2 238 orders of magnitude while retaining the most favorable sequences." The number of 239 conformations that undergo minimization (as described in [12] [13] [14] [15] ) for each partition . All of these residues were allowed to be 249 continuously flexible [12] [13] [14] [15] . The designs were selected from 40 different protein 250 structures (listed in S1 Table and also used in [32, 56] ), and were run on 40-48 core Intel 251
Xeon nodes with up to 200 GB of memory. The number of remaining sequences after fries was compared to the size of the 257 complete input sequence space. In the best case, when using fries, the sequence space 258 was decreased by more than 2 orders of magnitude and the conformation space was representing the reduction in the sequence space in percentages across all 2,662 designs. 7% of the designs had a reduction in sequence space over 95%, 24% of the designs had a reduction in sequence space between 66-95%, 31% of the designs had a reduction in sequence space between 36-65%, 32% of the designs had a reduction in sequence space between 6-35%, and 6% of the designs had a reduction in sequence space under 5%. (B) and (C) plot the number of sequences remaining after using fries starting with 441 and 9,261 sequences total, respectively. The number of sequences remaining for each design are sorted in order of decreasing size of the remaining conformation space after fries.
fries/EWAK * is up to 2 orders of magnitude faster than BBK* 263
The overall runtime was compared between BBK * and fries/EWAK * . fries/EWAK * 264 was an average of 62% faster than BBK * on 167 example design problems. fries We examined 661 K * score calculations, and concluded that the total number of 278 conformations minimized to approximate the K * score was decreased by an average of 279 27%. In the best case the number of conformations minimized to approximate the K * the groundwork for the prospective study we present that investigates novel mutations. 319
So, following the retrospective study, we computationally redesigned the PPI using If the ∆b value is less than 0, binding decreases. If the ∆b value is greater than 0, binding increases. If the ∆b value is close to 0, the effect is neutral. Quantitative values of K * tend to overestimate the biological effects of mutations (leading to the much larger blue bars) due to the limited nature of the input model compared to a biologically accurate representation. However, K * in general does a good job ranking variants, as can be seen here in Fig 6, in [1] , and in [38] . Out of the 41 variants listed on the x-axis, only 3 were predicted incorrectly (marked with black asterisks) by EWAK * . In terms of accuracy, BBK * performed very similarly to EWAK * (data not shown), however, in 2 cases (marked with green boxes), BBK * ran out of memory and was unable to calculate a score. BBK * also did not return values for the 2 variants marked with orange boxes. The variants marked with purple dots were tested in [49] experimentally -not computationally -and decreased binding of c-Raf-RBD to KRas GTP was observed, which EWAK * was able to predict correctly. The two variants marked with yellow triangles were computationally predicted in [49] to improve binding of c-Raf-RBD to KRas GTP . However, the experimental validation in [49] showed that these variants exhibit decreased binding, which EWAK * accurately predicted.
Out of the 41 variants tested (see S2 Table) , EWAK * predicted the experimentally-reported effect (increased vs. decreased binding) correctly in 38 cases.
343
The three designs where the effect was predicted incorrectly are marked with a star in 344 designs that contain more simultaneous mutations and more flexible residues.
359
Finally, we compared our predictions to the interesting biological predictions in [49] . 360
It is unclear how many mutants were computationally evaluated, but the authors do 361 report computational predictions for 6 point mutations. Of those, point mutants R67L, 362 N71R, and V88I were predicted to improve the intermolecular interactions between 363 c-Raf-RBD and KRas GTP . However, experiments found that R67L and V88I actually 364 reduced the binding of c-Raf-RBD to KRas GTP [49, 64] . In contrast to [49] , EWAK * 365 accurately predicted that these mutations decrease binding of c-Raf-RBD to KRas GTP . 366
For a more detailed view of one of these designs, V88I, see Fig 7. Additionally, a 367 number of mutations were combined and experimentally tested in [49] . Unfortunately, 368 none of these variants improved binding to either KRas GTP or KRas GDP , which fries/EWAK * correctly predicted computationally ( Fig 5) . In [49] , the authors do not 370 present any computational predictions for these combined variants, but our results show 371 that a computational prediction using osprey's EWAK * would have saved the time and 372 resources taken to experimentally test these variants. . A mutation to isoleucine at this position was computationally predicted by EWAK * to decrease the binding of c-Raf-RBD to KRas GTP . This was experimentally validated in [49] , where the authors incorrectly computationally predicted the effect of this particular mutation on the binding of c-Raf-RBD to KRas GTP . (A) The wild-type residue (valine) is shown in green with dots that indicate molecular interactions [66] with the surrounding residues (residues allowed to be flexible in the design are shown as lines). (B) The mutant residue (isoleucine) is shown in blue with dots that indicate molecular interactions [66] with the surrounding residues (residues allowed to be flexible in the design are shown as lines). Contacts made by the wild-type valine residue (circled dots in (A)) were lost upon mutation to isoleucine (circled space in (B)). (C & D) A set of 10 low-energy conformations that were included in the corresponding partition function calculation are shown for the wild-type (green) and the variant (blue).
only the most favorable sequences (as described in the Section entitled "Fast Removal of 389
Inadequately Energied Sequences (fries)") and then EWAK * was used to estimate the 390 K * scores (as described in the Section entitled "Energy Window Approximation to K* 391 (EWAK * )"). We report the upper and lower bounds on the EWAK * score for each 392 design in Table 1 (also see S3 Table) , where the listed sequences are those that were not 393 pruned during the fries step. From these results, the predicted binding effect 394 (increased vs. decreased) was determined based on comparing each variant's K * score to 395 its corresponding wild-type K * score. We then selected 5 novel point mutations -that 396 to our knowledge are not reported in any existing literature -for experimental 397 validation ( Table 1) . It is worth noting that these 5 point mutations were selected out 398 of an initial 294 possible mutations. We limited our experimental validation to only 399 these 5 new mutations and 2 previously reported mutations. This greatly reduced the 400 amount of resources necessary for experimental validation compared to testing all 294 401 possibilities. These mutations were selected based on having a promising K * score and 402 through examining structures calculated by EWAK * . Of the mutations selected, T57M 403 was selected to act as a variant that was computationally predicted to be comparable to 404 wild-type. This variant was included to further verify the accuracy of osprey's 405 predictions. On the other hand, some of osprey's top predictions were excluded, for 406 instance, T57R (included in S3 Table) was not selected for experimental testing because 407 it has an unsatisfied hydrogen bond as evidenced in the structures calculated by 408 osprey. Therefore, we do not believe that the score accurately represents the effect the 409 mutation will have. Other excluded top predictions (see S3 Table) displayed similar 410 characteristics or have been reported and tested previously [49, 64, 65] . The mutations selected (highlighted in Table 1 ) from computational design were 414 experimentally validated using a bio-layer interferometry (BLI) assay. Results from an 415 initial single-concentration BLI screen (Fig 8) suggested that, contrary to the 416 computational predictions, the T57K and V88F variants decrease binding, whereas the 417 T57M and K87Y mutations both have a roughly neutral effect on binding, which is Table 1 . Computational predictions by osprey/fries/EWAK * that were selected for experimental validation. Each row of the table shows the results of the redesign of a residue position in c-Raf-RBD in the c-Raf-RBD:KRas PPI that were also selected for experimental validation (all of the computational results are listed in S3  Table) . The table contains the values for upper and lower bounds on log(K * ) values (the calculation of these bounds is described in detail in [32] ). Mutations highlighted in yellow, blue, and pink were selected for experimental testing and validation. The two residues highlighted in blue are the best previously discovered [49] mutations that improve binding (independently and additively) and are included in our tightest binding variant, c-Raf-RBD(RKY) (Figs 9, 8, and 10) . The variants highlighted in yellow are, to the best of our knowledge, never-before-tested variants that are predicted to increase the binding of c-Raf-RBD to KRas GTP . The variant highlighted in pink was selected for experimental testing to act as a mutation predicted to be comparable to wild-type to test how accurately osprey predicted the effects of these mutations. with A85K or N71R, two previously reported variants also predicted by osprey and predicted by fries/EWAK * to bind to KRas GTP more tightly than the previous best 429 known binder, c-Raf-RBD(RK) (results are detailed in Fig 9) . Given the promising panel (A) ). The c-Raf-RBD(RKY) variant (in green on the far left) is a novel, newly discovered variant of c-Raf-RBD. Top variants were further validated and had their K d values calculated more accurately using BLI titration experiments (Fig 10) . When valine is mutated to tyrosine (shown in cyan), the lysine at position 84 moves to make room for the tyrosine and positions itself to hydrogen bond with both the aspartate and the glutamate (labeled) in KRas.
ligand in a BLI-based assay (Fig 10) . Excitingly, c-Raf-RBD(RKY) is calculated by the 433 data from the BLI assay (Figs 8 and 10) to bind KRas GTP roughly 5 times better than 434 the previous best known binder, c-Raf-RBD(RK), and approximately 36 times better 435 than wild-type c-Raf-RBD. Given how heavily studied the KRas system is, with several 436
reported mutational and structural studies [49, 64, 64, 65, 65, 67, 67-73, 73, 74, 74-79] , this 437 is a discovery of some significance. Each variant of c-Raf-RBD was expressed and purified (S2 Text) with cysteine residues 441 at positions 81 and 96 substituted for isoleucine and methionine, respectively. These Table) . The values presented here for Wild-Type, A85K, and c-Raf-RBD(RK) agree well with previously reported K d values [49] . The best binding variant, c-Raf-RBD(RKY), binds to KRas about 5 times better than the previous tightest-known binder, c-Raf-RBD(RK), and about 36 times better than wild-type c-Raf-RBD.
mutations were previously reported to minimally affect on the stability of 443 c-Raf-RBD [73] and their substitution allows for the use of the c-Raf-RBD constructs in 444 other assays (not mentioned herein). Additionally, we do not believe these residue (fries)"), decreasing the size of the sequence space by more than 2 orders of magnitude, 473
and leading to more efficient design given the smaller search space.
474
To further validate osprey with fries/EWAK * , we applied these algorithms to a 475 biomedically significant design problem: the c-Raf-RBD:KRas PPI. First, we performed 476 a series of retrospective designs where fries/EWAK * accurately predicted how a variety 477 of mutations affect the binding of c-Raf-RBD to KRas GTP that previous computational 478 methods had failed to accurately predict [49] . This success supports the use of osprey 479
and fries/EWAK * to evaluate the effect mutations in the protein-protein interface of 480 c-Raf-RBD:KRas have on binding (more, similar successes of the K * algorithm are 481 presented and discussed in [1] ). fries/EWAK * also prospectively predicted the effect of 482 new mutations in the c-Raf-RBD:KRas PPI and discovered a novel c-Raf-RBD 483 mutation V88Y with improved affinity for KRas. We went on to combine this new 484 mutation with two previously reported mutations, N71R and A85K [49] , to create 485 c-Raf-RBD(RKY), an even stronger binding c-Raf-RBD variant, which fries/EWAK * 486 accurately predicted. We biochemically screened top predicted variants using an initial 487 bio-layer interferometry (BLI) single-concentration assay. Only a promising subset of 488 the computationally predicted and initially screened variants were then evaluated using 489 a BLI titration assay to calculate K d values for individual c-Raf-RBD variants. We interaction [64, 65, [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] and performed mutagenesis on c-Raf-RBD either, through 495 rational means [64, 67, 74, 78] , computational methods [49, 65] or high-throughput 496 evolutionary methods [73, 79] and that none identified V88Y, this discovery validates 497 our computational approach and the use of computational algorithms such as fries and 498 EWAK * to redesign protein-protein interfaces toward improved binding. Finally, 499 previous mutations that enhanced the affinity of c-Raf-RBD binding to KRas did so by 500 supercharging c-Raf-RBD [49, 64, 65] . In contrast, our mutation V88Y introduces a Each protein structure has its PDB ID listed along with its molecule names as 513 presented in the Protein Database entry for each structure. Individual designs are not 514 listed or described here, but the necessary code and data is provided for the interested 515 reader (see Data availability statement).
516
S2 Table. Experimental and computational percent change in binding and 517 rankings. For each listed variant, we give the experimental percent change in binding 518
relative to wild-type as reported in [64] and as calculated from reported binding values 519 in [65] and [49] , the EWAK * computationally predicted percent change in binding (as 520 described in the Section entitled "fries/EWAK * retrospectively predicted the effect mutations in c-Raf-RBD have on binding to KRas") and the rankings that correspond 522
to these values. The rankings have a Pearson correlation of 0.81.
523
S3 Table. Table of computational values (these bounds are described in detail in [32] 
